The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

First-line CyborD treatment for graft ineligible multiple myeloma patients: Real-life efficacy and tolerability.

Dominic  Duquette

Consulting or Advisory Role - Janssen

Speakers' Bureau - Amgen; Celgene; Janssen; Roche Canada; Teva Innovation Canada

Marie-Michelle  Germain

No Relationships to Disclose